Bausch Health Companies | VRX - Gross Profit On Sales

Stock Price
6.95
Daily Change
-0.07 -0.93%
Monthly
-17.03%
Yearly
-31.71%
Q1 Forecast
6.65

Bausch Health Companies reported $1.93B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Amgen USD 6.48B 307M Sep/2025
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Bausch Health Companies USD 1.93B 165M Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Canopy Growth CAD 21.9M 3.86M Sep/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Drreddys Laboratories INR 46.81B 10.24B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pacira USD 142.25M 11.34M Dec/2025
Perrigo USD 362.2M 14.9M Dec/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Supernus Pharmaceuticals USD 164.04M 15.23M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025
Zoetis USD 1.64B 73M Dec/2025